skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ripretinibQuestion & answer

ripretinib · Medicine question

Which two principal kinase targets does ripretinib inhibit?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Ripretinib inhibits KIT proto-oncogene receptor tyrosine kinase and PDGFRA kinase, including wild-type forms and primary and secondary mutations.

Sources for this answer

QINLOCK 50 mg tabletsDeciphera · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated 15 April 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about ripretinib

Can ripretinib affect the ability to drive or use machines?Can ripretinib cause hand-foot syndrome (palmar-plantar erythrodysaesthesia)?Can ripretinib harm an unborn baby during pregnancy?Can ripretinib impair wound healing?How does itraconazole affect ripretinib exposure?How long is effective contraception required after stopping ripretinib?

ripretinib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the ripretinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX